सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

NIMHANS study demonstrates promise in intranasal therapy for Parkinson’s disease

GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims·

Why in news

NIMHANS researchers reported promising pre-clinical results for a non-invasive intranasal therapy using dental pulp stem cell-derived exosomes to treat Parkinson's disease in rats.

Background

The study was funded by the Indian Council of Medical Research (ICMR) and the Department of Science and Technology. The therapy showed improvements in motor coordination, dopamine levels, neurotransmitter balance, and inflammatory markers in rats.

Facts for Prelims

  • S&TExosomes: Extracellular vesicles used in the study derived from dental pulp stem cells.
  • BodyICMR: Indian Council of Medical Research, which funded the study.
  • FactSubstantia nigra: The specific brain region affected by Parkinson's disease targeted by the therapy.
  • S&TIntranasal therapy: A non-invasive delivery method for the stem cell-derived exosomes.

For Mains

Q. Discuss the potential of stem cell-derived therapies and regenerative medicine in addressing neurodegenerative disorders like Parkinson's disease in India.

Dimensions to cover in your answer

  • Regenerative potential: Ability of exosomes to trigger dopaminergic neuron regeneration in the substantia nigra
  • Clinical translation: Transitioning from successful rat models to human clinical trials and safety protocols

Keywords: Regenerative Medicine · Neurodegenerative Disorders · Stem Cell Therapy · Biotechnology · Dopaminergic Neurons

Read the full news →Source: The Hindu ↗Also: GS2 · Health policy & public health

More Science & Technology notes

All Science & Technology current affairs →

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.